Jubilant Generics Hiring Pharmacovigilance Executive - Apply Online

Jubilant Generics Hiring Pharmacovigilance Executive – Apply Online

Jubilant Generics (JGL) is a wholly-owned subsidiary of Jubilant Pharma. JGL in India has Research & Development units at Noida and Mysore. It has two manufacturing facilities one at Mysore, Karnataka and another at Roorkee, Uttarakhand, engaged in APIs and Dosage manufacturing, respectively.

The manufacturing location at Mysore is spread over 69 acres and it’s a USFDA approved site engaged in the manufacturing of APIs, and caters to sales worldwide. API portfolio focuses on Lifestyle driven Therapeutic Areas (CVS, CNS) and targets complex and newly approved molecules. The company is the market leader in four APIs and is amongst the top three players for another three APIs in its portfolio helping it maintain a high contribution margin. The manufacturing location at Roorkee, Uttarakhand is a state of a art facility and is audited and approved by USFDA, Japan PMDA, UK MHRA, TGA, WHO, and Brazil ANVISA. This business focuses on B2B model for EU, Canada, and emerging markets.

Job Title: Executive-Pharmacovigilance

Qualification– M.Pharmacy

Experience – Upto 2 Yrs

Location– Noida

  • ICSR data entry, evaluation, reporting, review, follow-up, and reconciliation: assist with review of responses to pharmacovigilance queries and database reconciliation, as required.
  • Preparation of aggregate reports/periodic reports such as e.g. PSURs, ADSRs.
  • Preparing/updating Risk management plans.
  • Contributing/Preparing Regulatory Medical Writing deliverables including but not limited to Clinical Overviews, Non-Clinical Overviews, Addenda to Clinical/Non-Clinical Overviews

Apply Online

Editors Note: Jubilant Generics Hiring Pharmacovigilance Subscribe to Rasayanika for the latest chemistry and Pharma job openings, follow us on Facebook and Telegram and subscribe to our youtube channel for the latest updates on chemistry and Pharma jobs and much more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here